Speakers
Leaders of Ophthalmology
This year our Keynote Speaker is Tom Burns, CEO of Glaukos. He will be interviewed by the Jim Mazzo, Zeiss.
Leaders of Ophthalmology
This year our Keynote Speaker is Tom Burns, CEO of Glaukos. He will be interviewed by the Jim Mazzo, Zeiss.
OTS 2019 Speakers
Eric Bernabei
Chief Sales & Marketing Officer, Avellino Labs
Tom Burns
CEO, Glaukos
Bill Carpou
CEO, OCTANe
Andy Corley
Principal, Yelroc Consulting
Jag Doanjh
Sr. Vice President, Eye Care, Allergan
Tom Frinzi
World Wide President, Surgical, Johnson & Johnson
A.J Ghergich
President Chief Technology Officer Digital Intelligence, Device Pharm
Kamran Hosseini, MD, PhD
President & CEO, Surface Pharmaceuticals
John Hovanesian, MD, FACS
Private Practice, Harvard Eye Associates, Clinical Faculty, UCLA Jules Stein Institute
Elad Kedar
CEO, Orasis Pharmaceuticals
Richard Lindstrom, MD
Founder & Attending Surgeon, Minnesota Eye Consultants
William Link, Ph.D
Principal, Flying L Partner & Founder, Managing Director, Versant Ventures
Bradford Manning
Two Blind Brothers
Bryan Manning
Two Blind Brothers
Caren Mason
President & CEO, STAAR Surgical
Cynthia Matossian, MD
Matossian Eye
Jim Mazzo
Global President of Ophthalmic Devices, Carl Zeiss Meditec, Inc.
Jason Menzo
Chief Operating Officer, Foundation Fighting Blindness
Tom Mitro
President & COO, Aerie Pharmaceuticals
Monty Montoya
President and CEO, CorneaGen
Raqiyyah R. Pippins, JD
Partner, Arnold & Palmer
David Pyott
Former CEO, Allergan
Sheri Rowen, MD
Ehsan Sadri, MD, FACS
Founding Member, Visionary Venture Fund
John Sheets, PhD
President, Elisar Health
Paul Stubenbordt
President Stubenbordt Consulting
Robert Thornhill
CEO, Tearfilm Innovations, A Divison of Alcon
Farrell "Toby" Tyson, MD
Tyson Eye
Jeffrey Weinhuff
Managing Partner, Visionary Venture Fund
Elizabeth Yeu, MD
Partner, Virginia Eye Consultants
Ophthalmology Technology Summit
Fashion Island Hotel, Newport Beach
Join Our Ecosystem
We’ll keep you updated on all things OCTANe.
OCTANe values your privacy. Please view our privacy policy here.
